| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/16/2007 | CA2641988A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 08/16/2007 | CA2641875A1 Pulmonary delivery of alpha-i proteinase inhibitor |
| 08/16/2007 | CA2641872A1 Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases |
| 08/16/2007 | CA2641859A1 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
| 08/16/2007 | CA2641854A1 Neutralization of bacterial spores |
| 08/16/2007 | CA2641638A1 A direct cellular energy delivery system |
| 08/16/2007 | CA2641588A1 Stabilized compositions of proteins having a free thiol moiety |
| 08/16/2007 | CA2641315A1 Osteoporosis associated markers and methods of use thereof |
| 08/16/2007 | CA2641310A1 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/16/2007 | CA2641198A1 Method for treating peripheral arterial disease with zinc finger proteins |
| 08/16/2007 | CA2640469A1 Amino acid derivatives |
| 08/16/2007 | CA2638911A1 Methods and compositions related to targeting tumors and wounds |
| 08/16/2007 | CA2638816A1 Inhibitors of membrane type-1 matrix metalloproteinase for the treatment of insulin-dependent diabetes mellitus |
| 08/16/2007 | CA2637786A1 Compositions and methods for enhancing neuronal plasticity and regeneration |
| 08/16/2007 | CA2637221A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | CA2637216A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | CA2636671A1 Modified coagulation factor vila with extended half-life |
| 08/16/2007 | CA2625981A1 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/15/2007 | EP1818409A1 Transfer of mRNAusing polycationic compounds |
| 08/15/2007 | EP1818395A1 Compositions and methods for treating lysosomal storage diseases |
| 08/15/2007 | EP1818342A2 Purified primate CTLA-8 antigens and related reagents |
| 08/15/2007 | EP1818341A2 Sheep lice, bovicula ovis, allergen treatment |
| 08/15/2007 | EP1818340A1 Glycopeptide antibiotic monomer derivatives |
| 08/15/2007 | EP1818062A1 An anti HSP90 antibody |
| 08/15/2007 | EP1818061A1 Use of ghrelin for stimulating hair growth |
| 08/15/2007 | EP1817337A1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 08/15/2007 | EP1817336A2 Auristatins having an aminobenzoic acid unit at the n terminus |
| 08/15/2007 | EP1817334A1 Fusion protein comprising a bh3-domain of a bh3-only protein |
| 08/15/2007 | EP1817332A2 Combinatorial interleukin-2 muteins |
| 08/15/2007 | EP1817330A2 Protein allergen derivatives |
| 08/15/2007 | EP1817328A2 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 08/15/2007 | EP1817066A2 Medical device for delivering biologically active material |
| 08/15/2007 | EP1817057A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 08/15/2007 | EP1817056A2 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 08/15/2007 | EP1817052A2 Compositions and methods for the treatment of autism |
| 08/15/2007 | EP1817051A2 Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose |
| 08/15/2007 | EP1817050A2 Diagnosis and treatment of alzheimer's disease |
| 08/15/2007 | EP1817049A1 Soluble, stable insulin-containing formulations with a protamine salt |
| 08/15/2007 | EP1817048A2 Stable formulations of insulinoptropic peptides |
| 08/15/2007 | EP1817047A2 Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
| 08/15/2007 | EP1817046A1 Novel antimicrobial peptides |
| 08/15/2007 | EP1817045A2 An oil-in-water nanoemulsion, a cosmetic composition and a cosmetic product comprising it, a process for preparing said nanoemulsion |
| 08/15/2007 | EP1817038A2 Combination comprising zd6474 and an antiandrogen |
| 08/15/2007 | EP1817016A2 Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds |
| 08/15/2007 | EP1817006A2 Liposomal formulation for oral administration of glutathione (reduced) |
| 08/15/2007 | EP1636263B1 Pegylated soluble gp130-dimers useful as a medicament |
| 08/15/2007 | EP1594516B1 Herbal compositions for prostate conditions |
| 08/15/2007 | EP1368372B1 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/15/2007 | EP1328288B1 Protein mixtures for wound healing |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | EP1280552B1 Methods of treating skin cancer using compositions comprising an inhibitor of endothelin receptor b |
| 08/15/2007 | EP1255109B1 Screening method |
| 08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1232251B1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 08/15/2007 | EP1187628B1 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 08/15/2007 | EP1137785B1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP0981618B1 Anti-apo-2 antibody |
| 08/15/2007 | EP0935673B1 Methods and devices for mass transport assisted optical assays |
| 08/15/2007 | EP0876610B1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 08/15/2007 | EP0869975B1 Assay for and uses of peptide hormone receptor ligands |
| 08/15/2007 | EP0784684B1 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN1332030C Polypeptide, its coding sequence and preparation method and application of fungus galactose agglutinin protein activity |
| 08/15/2007 | CN1332029C Mutant recombinant allergens |
| 08/15/2007 | CN1331882C Peptide of decreasing blood pressure of protein of acetes chinensis, preparing method and application |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331533C Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy |
| 08/15/2007 | CN1331532C Botulinum toxin pharmaceutical compositions |
| 08/15/2007 | CN1331531C Medicine for treating chronic gastritis |
| 08/15/2007 | CN1331530C Medicinal preparation for treating stomach and intestine diseases and its preparing method |
| 08/15/2007 | CN1331477C Medical nano-carbon tube composition, preparation method and its application |
| 08/15/2007 | CN1331468C Plant extractive for treating cancer |
| 08/15/2007 | CN101018859A Mucin 3 EFG-like domains |
| 08/15/2007 | CN101018808A Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/15/2007 | CN101018807A C1q family member proteins with altered immunogenicity |
| 08/15/2007 | CN101018805A Reagents for diagnosis and therapy of latex allergy and method for the preparation of the same |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation |
| 08/15/2007 | CN101018563A Antimicrobial peptides derived from CAP18 |
| 08/15/2007 | CN101018562A NELL peptide expression systems and bone formation activity of NELL peptide |
| 08/15/2007 | CN101018561A Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies |
| 08/15/2007 | CN101018560A Permucosal composition and method of improving permucosal absorption |
| 08/15/2007 | CN101018559A c-MET kinase binding proteins |
| 08/15/2007 | CN101016560A Method of measuring biologically active substance vitality, cardiomyopeptidin and use thereof |
| 08/15/2007 | CN101016548A Soluble conversion growth factor beta II type receptor/gamma-interferon recombination fusion albumen and preparation thereof |
| 08/15/2007 | CN101016340A Fusion polypeptide and use thereof in treatment of tumor and cell growth abnormity correlated disease |
| 08/15/2007 | CN101016339A Dual active protein containing stroma cell derivative factor-1 and immunoglobulin-Fc section, and application thereof |
| 08/15/2007 | CN101016333A RNase 9 protein, coded sequence and use thereof |
| 08/15/2007 | CN101016332A Short peptide for inhibiting Shiga toxin and application thereof |
| 08/15/2007 | CN101015686A Thrombolytic medicine synergist and its preparing process |
| 08/15/2007 | CN101015685A Cow nipple film coating protective agent and its preparing process |
| 08/15/2007 | CN101015684A Recombinant erythropoietin liquor preparation |
| 08/15/2007 | CN101015683A Application of human RTN4B protein in preparation of medicine for healing wound |
| 08/15/2007 | CN101015682A Medicine composition with compact bone substance density improving function, preparing process and quality controlling means thereof |
| 08/15/2007 | CN101015681A Medicine for treating chronic renal failure and its preparing process |
| 08/15/2007 | CN101015680A Medicine for improving immunity and treating malignant tumour and preparation process thereof |
| 08/15/2007 | CN101015679A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 08/15/2007 | CN101015678A Nutrient solution for treating patient intestinal dysfunction |